BRIEF-Dawnrays Pharmaceutical Reports HY Net Income Attributable Of RMB104.6 MLN
Reuters
Aug 22
BRIEF-Dawnrays Pharmaceutical Reports HY Net Income Attributable Of RMB104.6 MLN
Aug 22 (Reuters) - Dawnrays Pharmaceutical (Holdings) Ltd 2348.HK:
DECLARED INTERIM DIVIDEND OF HK$0.015 PER SHARE
DAWNRAYS PHARMACEUTICAL (HOLDINGS) H1 REVENUE RMB 630.4 MILLION
DAWNRAYS PHARMACEUTICAL (HOLDINGS) H1 NET INCOME ATTRIBUTABLE RMB 104.6 MILLION
Further company coverage: 2348.HK
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.